IL6 and hepatocellular adenoma: These findings suggest that CVF IL-6 could serve as a valid, non-invasive screening test for pregnant women to stratify risk for HCA, while a combination of AF, CVF, and plasma IL-6 could potentially serve as diagnostic tool for clinicians on this purpose.